Tg Therapeutics (TGTX) Leases: 2019-2025
Historic Leases for Tg Therapeutics (TGTX) over the last 7 years, with Sep 2025 value amounting to $6.5 million.
- Tg Therapeutics' Leases fell 12.28% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year decrease of 12.28%. This contributed to the annual value of $7.2 million for FY2024, which is 11.17% down from last year.
- As of Q3 2025, Tg Therapeutics' Leases stood at $6.5 million, which was down 3.23% from $6.7 million recorded in Q2 2025.
- Tg Therapeutics' Leases' 5-year high stood at $9.1 million during Q1 2021, with a 5-year trough of $6.5 million in Q3 2025.
- In the last 3 years, Tg Therapeutics' Leases had a median value of $7.7 million in 2024 and averaged $7.6 million.
- As far as peak fluctuations go, Tg Therapeutics' Leases grew by 3.36% in 2022, and later dropped by 12.38% in 2025.
- Quarterly analysis of 5 years shows Tg Therapeutics' Leases stood at $8.6 million in 2021, then grew by 3.00% to $8.9 million in 2022, then declined by 9.43% to $8.1 million in 2023, then fell by 11.17% to $7.2 million in 2024, then dropped by 12.28% to $6.5 million in 2025.
- Its last three reported values are $6.5 million in Q3 2025, $6.7 million for Q2 2025, and $6.9 million during Q1 2025.